| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604504 | International Journal of Cardiology | 2017 | 25 Pages |
Abstract
Vascular complications occurred more often in the Prostar® group. Although 30-day mortality showed no significant difference between the groups, the mortality over complete follow-up was significantly lower in the Proglide® group.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Zisis Dimitriadis, Werner Scholtz, Jochen Börgermann, Marcus Wiemer, Cornelia Piper, Mario Vlachojannis, Jan Gummert, Dieter Horstkotte, Stephan Ensminger, Lothar Faber, Smita Scholtz,